Publication

Characterization of the 5-HT7 receptor. Determination of the pharmacophore for 5-HT7 receptor agonism and CoMFA-based modeling of the agonist binding site

Vermeulen, ES., Schmidt, AW., Sprouse, JS., Wikstrom, HV. & Grol, CJ., 4-Dec-2003, In : Journal of Medicinal Chemistry. 46, 25, p. 5365-5374 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

  • ES Vermeulen
  • AW Schmidt
  • JS Sprouse
  • HV Wikstrom
  • CJ Grol

On the basis of a set of 20 diverse 5-HT7 receptor agonists, the pharmacophore for 5-HT7 receptor agonism was determined. Additionally two CoMFA models were developed, based on different alignments of the agonists. Both models show good correlations between experimental and predictive pK(i) values and show a high degree of similarity. The CoMFA fields were subsequently used to map the agonist binding site of the model of the 5-HT7 receptor. Important roles in ligand binding are attributed to Asp162 of TM3 (interaction with a protonated nitrogen), and Thr244 of TM5 (interaction with a substituent at an aromatic moiety). Amino acid residues of the aromatic cluster of TM6 are hypothesized to play an important role in ligand binding as pi-pi stacking moieties. Agonists missing a hydrogen-bond-accepting moiety, but possessing an aromatic substituent instead, seem to bind the receptor with high affinity as well by occupying a lipophilic pocket hosted by residues of TM5 and TM6.

Original languageEnglish
Pages (from-to)5365-5374
Number of pages10
JournalJournal of Medicinal Chemistry
Volume46
Issue number25
Publication statusPublished - 4-Dec-2003

    Keywords

  • MM3 FORCE-FIELD, SEROTONIN RECEPTOR, MOLECULAR MECHANICS, ADENYLATE-CYCLASE, CONFORMATIONAL SPACE, CIRCADIAN-RHYTHMS, CLONING, HYDROCARBONS, EXPRESSION, RHODOPSIN

ID: 4153713